Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Ann Surg. 2016 Mar;263(3):593–600. doi: 10.1097/SLA.0000000000001149

Table 1.

Demographics of the 675 patients

Variable Value (% or
range)
Gender
  Male 299 (44%)
  Female 376 (56%)
Median age, years (range) 60 (16–91)
Retroperitoneal location
  Abdomen 556 (82%)
  Pelvis 108 (16%)
  Unknown 11 (2%)
Median tumor size, cm (range) 17 (2–139)
Radiation-associated 14 (2%)
Grade
  Low 242 (36%)
  High 431 (64%)
Number of organs resected
  0 284 (42%)
  1 207 (31%)
  2 112 (16%)
  3 39 (6%)
  4 18 (3%)
  ≥5 15 (2%)
Histology*
  Liposarcoma: well-differentiated & myxoid 186 (28%)
  Liposarcoma: dedifferentiated, round cell & pleomorphic 213 (32%)
  Low-grade leiomyosarcoma 18 (3%)
  High-grade leiomyosarcoma 132 (20%)
  Solitary fibrous tumor 33 (5%)
  Malignant peripheral nerve sheath tumor 23 (3%)
  Translocation-associated and other 34 (5%)
  Not otherwise specified (NOS) 35 (5%)
Completeness of resection
  Exploratory laparotomy only (no resection) 43 (6%)
  R0 337 (50%)
  R1 237 (35%)
  R2 58 (9%)
Vascular resection performed 67 (10%)
Pre-operative radiation** 28 (4%)
Post-operative radiation 26 (4%)
Pre-operative chemotherapy** 73 (11%)
Post-operative chemotherapy 48 (7%)

MSKCC, Memorial Sloan Kettering Cancer Center;

*

One patient had an unresectable leiomyosarcoma of unknown grade.

**

Of the 89 patients (13%) who received pre-operative therapy, 16 (2%) received radiation only, 61 (9%) received chemotherapy only, and 12 (2%) received both.